Drug Database
CO

COVID-19 vaccine (Corbevax / RBD219 N1C1 / RBD219N1C1)

✓ Approved

Biological E Limited · 重组蛋白 · 重组蛋白

什么是 COVID-19 vaccine?

COVID-19 vaccine 是一种重组蛋白,由Biological E Limited研发。该药已获批,用于治疗相关适应症,给药途径:Injectable (Others)、Intramuscular (IM) Injection。

药物档案

商品名Corbevax, RBD219 N1C1, RBD219N1C1
公司Biological E Limited
药物类别重组蛋白, 疫苗
给药途径Injectable (Others), Intramuscular (IM) Injection
状态Approved

治疗适应症

COVID-19 vaccine 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Infections and infestationsCOVID-19✓ Approved

相关研究文献

PubMedBMJ public health2026-11-18

Responding to COVID-19: implementation of pandemic measures in Swiss nursing homes - a nationwide online survey.

Stephan Sophie S, Neuner-Jehle Stefan S, Senn Oliver O, Heinz Nathalie N et al.

The lives of nursing home residents were impacted by the direct and indirect effects of the COVID-19 pandemic, including high infection and mortality rates as well as protective measures that contributed to social isolation. This study examined the implementation and strictness of protective measures in Swiss nursing homes, changes following vaccine availability and factors associated with their adoption. We conducted a multilingual online survey of Swiss nursing home staff 2 years after the most intense phase of the pandemic. The primary outcomes were the maintenance and strictness of COVID-19 protective measures before and/or after vaccine availability. Structural and staffing characteristics were collected alongside detailed information on specific measures. Cluster analyses identified patterns of strictness across nursing homes. Logistic regression analyses examined factors associated with implementing strict measures before and after vaccine availability. A total of 671 Swiss nursing homes participated (response rate of 53%), of which 363 provided data on the primary outcomes. Most protective measures were eased following vaccine availability. Cluster analysis identified two groups of nursing homes that differed in the strictness of implemented measures, while largely maintaining their relative approach across both periods. In logistic regression analysis, location in the Italian-speaking region was most strongly associated with implementation of strict measures (OR=4.73, 95% CI 1.75 to 14.30, p=0.003 and OR=8.22, 95% CI 2.87-29.71, p<0.001, respectively before and after vaccine availability). Protective measures in Swiss nursing homes were generally implemented with a relatively high level of strictness across both periods, although substantial regional variation was observed. These differences may reflect sociocultural factors and local institutional policies. The findings underscore the need for continued ethical reflection on balancing infection control with residents' autonomy.

PMID 43048051
阅读全文 →
PubMedRevista brasileira de enfermagem2026-11-18

COVID-19 vaccination: adherence to immunization and adverse events in hospital workers.

Silva Luciana Pereira da LPD, Souza Célia Mariana Barbosa de CMB, Brum Maria Carlota MC, Hirakata Vânia Naomi VN et al.

to identify vaccination adherence and the prevalence of adverse events following COVID-19 vaccination among hospital workers. a longitudinal incidence study was conducted with 5,437 professionals vaccinated between January 2021 and December 2023, based on records from an institutional database. Associations were assessed using Pearson's chi-square test (α=0.05). overall adherence was 94.88%, with a progressive reduction in subsequent doses, predominantly among women aged 41 to 49 years (p<0.05). Physiotherapists showed higher adherence, while nurses, technicians, and assistants had lower rates. There were significant differences between vaccine types and the reporting of post-vaccination adverse events (p<0.001), which were more frequently reported by nurses and nursing technicians (p<0.05). communication and education strategies are fundamental to encouraging adherence to booster doses, strengthening confidence in vaccination, and guiding public policies for the protection of hospital workers.

PMID 43048990
阅读全文 →
PubMedHealth services research2026-11-18

Methods to Account for Competing Events With Unknown Duration in Health Policy Evaluations: The Case of COVID-19.

Easterly Caleb W CW, Trogdon Justin G JG, Holmes G Mark GM, Domino Marisa Elena ME

To compare methods for estimating policy effects in the presence of competing events such as COVID-19. We created a simulation study to evaluate how single interrupted time series (ITS) and comparative interrupted time series (CITS) estimators performed when policy implementation occurred near a competing event (COVID-19). The onset of the competing event was known (March 2020) but the duration was unknown. ITS approaches included assuming different COVID-19 durations (ITS-Assume) or searching for the COVID-19 duration that provided the best fit to the data (ITS-Grid Search). Outcomes included percent bias, power, and Type 1 error. We varied the duration of COVID-19 effects, the time between the policy implementation and COVID-19 onset, and the magnitude and sign of the policy effects relative to COVID-19 (2080 scenarios). Each simulated time series had 99 monthly observations (October 2015-December 2023). CITS had the lowest bias and Type 1 error and had high power across scenarios, except for intercept changes and when assumptions about shared COVID-19 effects between treatment and control groups were violated. ITS-Grid Search had lower bias and Type 1 error than ITS-Assume, which produced biased parameter estimates when the assumptions were incorrect. Estimates were more accurate when the policy was implemented prior to the competing event. Using estimation approaches that leverage control groups, such as CITS, can mitigate the potential bias of competing events in ITS frameworks, but these approaches are biased when competing event effects differ between treatment and control groups. Searching for the best-fitting competing event duration does not require a control group and outperforms methods that assume the duration of competing event effects a priori. More generally, researchers should be cautious about bias, specification error, and low power when using ITS methods with competing events.

PMID 43046543
阅读全文 →
PubMedBiotechnology and bioengineering2026-11-18

Increasing Adenovirus Upstream Process Productivity Using a High Cell Density Perfusion Strategy.

Roßkamp Alena A, Vieira Jacqueline J, Hussain Shawkat S, Talarek Julia J et al.

Adenovirus vectors are a major vaccine platform and have potential roles as oncolytics and gene therapies. Large-scale production of adenovirus-vectored COVID-19 vaccines demonstrated the value of platform manufacturing processes for such products but vaccine scarcity remained problematic in 2021. There is a need for widely-accessible and higher-yielding platform processes for adenovirus production. Such processes must overcome cell-density-associated productivity limitation and the potential impact of vector transgene expression. We report a process capable of upstream productivity of 3 ×1012 virus particles per mL, solely using commercially-accessible materials. This combines perfusion cell culture with a highly-productive cell line capable of vector transgene repression. Using a multi-parallel scaledown perfusion bioreactor system, we selected straightforward perfusion conditions for both expansion of uninfected cells and virus production. This achieves maintenance of high cell-specific productivity at cell densities up to 40 ×106 cells per mL. We believe this may be the highest productivity yet reported for an adenovirus platform, including previous reports using proprietary cell lines. This highly productive process could be valuable both in large-scale production and in maximizing the output of smaller facilities making products for niche indications or stockpiles.

PMID 43049530
阅读全文 →
PubMedCureus2026-11-18

Maternal Vaccine Receipt, Intentions, and Refusal Among Pregnant Women Attending Antenatal Care in Panama City: A Cross-Sectional Study.

Lucas Quintero Ana A, DeAntonio Rodrigo R, Escobar Luis L, Flores Luis Alberto LA et al.

Background/objectives Maternal vaccination surveys often combine willingness and receipt, potentially obscuring differences between these measures. We quantified self-reported vaccine receipt, intention without receipt, complete reported receipt, and refusal in an urban Panamanian convenience sample and examined their relationship with vaccination recommendation. Methods We analyzed an anonymous cross-sectional survey completed from March 26 to July 25, 2026, by 204 pregnant women aged 18 years or older recruited in health-related settings in Panama City. Self-reported receipt meant reporting at least one maternal vaccine during the current pregnancy. Intention without receipt meant planning at least one vaccine without reporting receipt of any specific vaccine. Complete reported receipt was the independent response "already received all," rather than verified completion of a vaccination schedule. Modified Poisson regression with robust variance estimated prevalence ratios (PRs). A secondary, post hoc evaluation examined six rating items without claiming formal questionnaire validation. Results The number of women who chose self-reported receipt was 128/204 (62.7%; exact 95% confidence interval (CI), 55.7-69.4), while the composite of receipt or intention was 190/204 (93.1%). Intention without receipt was reported by 62/204 (30.4%), complete reported receipt by 41/204 (20.1%), and refusal with coexisting receipt or intention by 92/204 (45.1%). Four participants reporting complete receipt did not report any vaccine-specific receipt. Refusal was reported for COVID-19 by 96/204 (47.1%), influenza by 11/204 (5.4%), tetanus, diphtheria, and acellular pertussis (Tdap) by 8/204 (3.9%), and respiratory syncytial virus (RSV) by 7/204 (3.4%). Receipt was reported by 126/172 (73.3%) participants with a vaccination recommendation versus 2/32 (6.2%) without one (adjusted PR, 11.28; 95% CI, 2.95-43.17). Three-item standardized Cronbach's alpha values were 0.699 and 0.728, with substantial ceiling effects and an unstable two-factor solution. Conclusions In this convenience sample, stated acceptance coexisted with the absence of reported receipt and vaccine-specific refusal. Recommendation was associated with receipt, but the estimate was imprecise and noncausal. These findings are not population estimates and support reporting recommendation, intention, receipt, and refusal separately. Intention without receipt does not establish subsequent failure to vaccinate.

PMID 43048589
阅读全文 →
PubMedBMC research notes2026-11-18

Meningitis vaccination campaign in the context of COVID-19 in Cameroon.

Mbang Marie Angèle MA, Amani Adidja A, Cheuyem Fabrice Zobel Lekeumo FZL, Tchamani Rick R et al.

The study aimed to describe the challenges, best practices, and lessons learned during meningitis vaccination campaigns conducted in the context of COVID-19 in Cameroon in 2020. During the prevention campaigns, 3460 individuals were selected and all were tested before the campaign (100%). Eight cases were positive, representing a positivity rate of 0.23% (8/3,460). The campaign was carried out using a fixed strategy in health facilities and prisons, and a fixed-temporary strategy in communities. Most health areas received sufficient quantities of COVID-19 equipment for some items and insufficient quantities for others. No screening was done during or after the campaign. The main difficulties encountered were compliance with social distancing and the continuous wearing of gowns. The challenges faced were the screening of actors and the use of personal protective equipment. aspects related to COVID-19 impacted the speed of the campaign. Vaccination coverage ranged from 91% to 140% in prisons on the one hand, and from 35% to 112% in the health areas surrounding prisons on the other. The campaign conducted in the context of COVID-19 was effective. Compliance with barrier measures was not optimal due to difficulties encountered with aspects such as social distancing, continuous wearing of gowns, screening of participants during and after the campaign, and insufficient personal protective equipment.

PMID 43046087
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多COVID-19 vaccine